Literature DB >> 30359560

Mosaicism in CRISPR/Cas9-mediated genome editing.

Maryam Mehravar1, Abolfazl Shirazi2, Mahboobeh Nazari3, Mehdi Banan4.   

Abstract

The CRISPR/Cas9 system is a rapid, simple, and often extremely efficient gene editing method. This method has been used in a variety of organisms and cell types over the past several years. However, using this technology for generating gene-edited animals involves a number of obstacles. One such obstacle is mosaicism, which is common in founder animals. This is especially the case when the CRISPR/Cas9 system is used in embryos. Here we review the pros and cons of mosaic mutations of gene-edited animals caused by using the CRISPR/Cas9 system in embryos. Furthermore, we will discuss the mechanisms underlying mosaic mutations resulting from the CRISPR/Cas9 system, as well as the possible strategies for reducing mosaicism. By developing ways to overcome mosaic mutations when using CRISPR/Cas9, genotyping for germline gene disruptions should become more reliable. This achievement will pave the way for using the CRISPR technology in the research and clinical applications where mosaicism is an issue.
Copyright © 2018. Published by Elsevier Inc.

Keywords:  CRISPR/Cas9; Mosaic mutations

Mesh:

Year:  2018        PMID: 30359560     DOI: 10.1016/j.ydbio.2018.10.008

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  54 in total

1.  CRISPR/Cas9-Mediated Transgenesis of the Masu Salmon (Oncorhynchus masou) elovl2 Gene Improves n-3 Fatty Acid Content in Channel Catfish (Ictalurus punctatus).

Authors:  Baofeng Su; Shangjia Li; Max Bangs; David Creamer; Michael Coogan; Jinhai Wang; Rhoda Simora; Xiaoli Ma; Darshika Hettiarachchi; Veronica Alston; Wenwen Wang; Andrew Johnson; Cuiyu Lu; Tasnuba Hasin; Zhenkui Qin; Rex Dunham
Journal:  Mar Biotechnol (NY)       Date:  2022-04-13       Impact factor: 3.619

Review 2.  3R measures in facilities for the production of genetically modified rodents.

Authors:  Branko Zevnik; Boris Jerchow; Thorsten Buch
Journal:  Lab Anim (NY)       Date:  2022-05-31       Impact factor: 9.667

Review 3.  Application of CRISPR/Cas9 System in Establishing Large Animal Models.

Authors:  Yingqi Lin; Jun Li; Caijuan Li; Zhuchi Tu; Shihua Li; Xiao-Jiang Li; Sen Yan
Journal:  Front Cell Dev Biol       Date:  2022-05-17

Review 4.  CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment.

Authors:  Fatima Akram; Ikram Ul Haq; Sania Sahreen; Narmeen Nasir; Waqas Naseem; Memoona Imitaz; Amna Aqeel
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 5.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

6.  Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.

Authors:  Ignacio García-Tuñón; Elena Vuelta; Laura Lozano; María Herrero; Lucía Méndez; Javier Palomero-Hernandez; María Pérez-Caro; Jessica Pérez-García; Rogelio González-Sarmiento; Manuel Sánchez-Martín
Journal:  Mol Biol Rep       Date:  2019-12-12       Impact factor: 2.316

Review 7.  Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application.

Authors:  Kateryna Kratzer; Landon J Getz; Thibaut Peterlini; Jean-Yves Masson; Graham Dellaire
Journal:  Hum Genet       Date:  2021-04-08       Impact factor: 4.132

8.  Improved efficiency of genome editing by constitutive expression of Cas9 endonuclease in genetically-modified mice.

Authors:  Bita Ghassemi; Monire Jamalkhah; Gelareh Shokri; Mousa Kehtari; Masoud Soleimani; Mehdi Shamsara; Jafar Kiani
Journal:  3 Biotech       Date:  2021-01-11       Impact factor: 2.406

9.  Conditional gene knockdowns in sea urchins using caged morpholinos.

Authors:  Anirban Bardhan; Alexander Deiters; Charles A Ettensohn
Journal:  Dev Biol       Date:  2021-03-05       Impact factor: 3.148

Review 10.  Current status of the application of gene editing in pigs.

Authors:  Fuminori Tanihara; Maki Hirata; Takeshige Otoi
Journal:  J Reprod Dev       Date:  2021-04-10       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.